Some MAHA Supporters Say CNPV Could Lower FDA Standards

By Maaisha Osman / October 23, 2025 at 2:01 PM

As the Trump administration aim to speed up drug approvals through the FDA’s new Commissioner’s National Priority Voucher program, some critics from the “Make America Healthy Again” movement argue the push could fuel overprescription of medicines, weaken scientific standards and put patient safety at risk.


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.